Budapest, Hungary

Jozsef Repasi

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Prosidion Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jozsef Repasi. Retrieved from https://idiyas.com/inventor/jozsef-repasi-0qyeysfm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jozsef Repasi: Innovator in Glycogen Phosphorylase Inhibition

Introduction

Jozsef Repasi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit glycogen phosphorylase. His work is essential for advancing therapeutic options for various health conditions.

Latest Patents

Jozsef Repasi holds a patent for a novel pyrrolopyridine-2-carboxylic acid amide derivative. This compound is recognized for its utility as an inhibitor of glycogen phosphorylase. The patent outlines the unique formula of the compound, its therapeutic applications, and the processes for its production. The invention also includes novel intermediates that are crucial for synthesizing the compound.

Career Highlights

Jozsef Repasi is associated with Prosidion Limited, where he continues to innovate in the field of drug development. His expertise in medicinal chemistry has positioned him as a key player in the research and development of new therapeutic agents.

Collaborations

Jozsef has collaborated with András Szabó, contributing to the advancement of their shared research goals. Their partnership has fostered innovation and has led to the successful development of new compounds.

Conclusion

Jozsef Repasi's work in developing glycogen phosphorylase inhibitors showcases his commitment to advancing medical science. His contributions are vital for the future of therapeutic interventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…